- Tytuł:
- 76P Immune checkpoint inhibitor (ICI) retreatment patterns and outcomes in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who received second-line or later (2L+) nivolumab (nivo): A French I-O optimise analysis
- Autorzy:
- Źródło:
- In Immuno-Oncology and Technology December 2023 20 Supplement
Czasopismo naukowe